NOW Glucomannan 575 mg vs Supergut GLP-1 Daily Support (formerly GLP-1 Booster)
The published reviews of NOW Glucomannan 575 mg and Supergut GLP-1 Daily Support (formerly GLP-1 Booster), lined up: the five scores, what one serving delivers against the studied dose, the real cost per serving and what each label leaves out. Figures as of 25 September 2026.
Supergut GLP-1 Daily Support (formerly GLP-1 Booster)
3.8/10
No dated price on file
Read the reviewThe short answer
NOW Glucomannan 575 mg scores 5.8/10 against Supergut GLP-1 Daily Support (formerly GLP-1 Booster)'s 3.8. The widest gap is dose against the studied amount: 6 for NOW Glucomannan 575 mg, 2 for Supergut GLP-1 Daily Support (formerly GLP-1 Booster).
Pick NOW Glucomannan 575 mg if…
- you want a serving that matches the amount used in research
- you want every amount on the label disclosed
- you want better value against the plain generic version
Pick Supergut GLP-1 Daily Support (formerly GLP-1 Booster) if…
- tolerability and a well-characterised safety record come first
Criterion by criterion
The five criteria every review is scored on, published on the grading page. The overall score is their average.
Evidence for the marketed claim
How strong the research is for what the product is actually sold to do — not for the ingredient in general.
Dose against the studied amount
Whether one serving delivers the amount used in the research behind the claim.
Label transparency
Whether the Supplement Facts panel is published in readable text and every active amount is disclosed.
Value against the generic equivalent
Cost per gram or per dose of the active ingredient, compared with the plainest version of the same thing.
Safety and tolerability
Known risks and interactions, how well characterised they are, and whether the label warns about them.
Dose against the studied amount
What one labelled serving delivers, placed against the range on each ingredient’s evidence page. Where a label gives no figure, there is nothing to place, and that is the finding.
GlucomannanEvidence D
Trial range: 1–4 g a day
- NOW Glucomannan 575 mg1,725 mg per 3-capsule serving (up to 3,450 mg a day on the label)In range
- Supergut GLP-1 Daily Support (formerly GLP-1 Booster)Not in the formula
What it actually costs
Price divided by labelled servings, from a dated listing. A serving is whatever the label calls one, which is why the studied-dose row matters more than the headline figure.
- $0.45 a serving · $26.99 for 60 servings at Amazon, checked 23 Sept 2026
- $60 for 40 scoops, or $48 on subscription, unflavored (25 Sept 2026). No per-serving figure: servings not recorded.
Label checks
What each label discloses, and what it leaves out. Read from the reviews, not from the marketing.
NOW Glucomannan 575 mg
- Every active ingredient has a stated amount
- No third-party certification
Supergut GLP-1 Daily Support (formerly GLP-1 Booster)
- 4 of 5 listed ingredients have no stated amount
- No third-party certification
How this comparison is built
- Scores are the ones already published in each review. Nothing is re-scored for the comparison, and a product leads a criterion only when it outscores the rest.
- Doses are read from the label rows in each review and placed against the studied range on the matching ingredient page. A figure that is not printed is never estimated.
- Costs use a dated retailer price divided by labelled servings. Prices in different currencies are never ranked against each other.
- Only products in the same category, or ones a review names as an alternative, can be compared. Commission never changes what appears here.